Abecassis Michael M
SEC insider (Form 3/4/5 filer). CIK 0001879281. Director at PharmaCyte Biotech, Inc. (PMCB). 5 reported Form 4/5 transactions since Sep 2024; latest on Mar 31, 2026. Located in LAS VEGAS, NV.
Companies Abecassis Michael M has filed insider reports for
- PharmaCyte Biotech, Inc. (PMCB): Director
Abecassis Michael M
CIK: 0001879281
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PharmaCyte Biotech, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Mar 31, 2026PMCB
PharmaCyte Biotech, Inc.
OtherDirectStock Option (Right to Buy)
0 shares- - Mar 31, 2026PMCB
PharmaCyte Biotech, Inc.
AwardDirectStock Option (Right to Buy)
119.2K shares- - Dec 12, 2025PMCB
PharmaCyte Biotech, Inc.
AwardDirect37.5K shares- - Dec 12, 2025PMCB
PharmaCyte Biotech, Inc.
Tax PaymentDirect16.9K shares at avg. $1.02$17K - Apr 25, 2025PMCB
PharmaCyte Biotech, Inc.
AwardDirectStock Option (Right to Buy)
63.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 31, 2026 | PMCB PharmaCyte Biotech, Inc. | Other Stock Option (Right to Buy) | 0 | - | - | Direct |
| Mar 31, 2026 | PMCB PharmaCyte Biotech, Inc. | Award Stock Option (Right to Buy) | 119,170 | - | - | Direct |
| Dec 12, 2025 | PMCB PharmaCyte Biotech, Inc. | Award | 37,500 | - | - | Direct |
| Dec 12, 2025 | PMCB PharmaCyte Biotech, Inc. | Tax Payment | 16,875 | $1.02 | $17,213 | Direct |
| Apr 25, 2025 | PMCB PharmaCyte Biotech, Inc. | Award Stock Option (Right to Buy) | 63,233 | - | - | Direct |
1-5 of 5 transactions